AI-Driven 'Exercise Pill' Passes Human Trial, Revolutionizing Drug Discovery
TansuYegen · x · 2026-08-20
Enveda's AI-developed experimental "exercise pill," ENV 308, has cleared Phase I trials, showing safety and tolerability. The drug aims to mimic exercise-induced molecules to maintain weight loss and muscle mass without the gastrointestinal side effects of GLP-1 drugs. This highlights how AI is transforming drug discovery from finding a needle in a haystack to searching the entire haystack, accelerating the convergence of AI, biology, and medicine.
More from Apps
- 7 prompts to turn your laptop into a free streaming center — Med1_Ai · 2026-08-20
- Raycast V2 launches with AI Chat upgraded to Agent and memory support — vista8 · 2026-08-20
- Prem Launches Cyberscan Security Agent Powered by Open-Source Models — Scobleizer · 2026-08-20
- Raycast V2 beta adds AI voice input with custom prompts and per-app styles — vista8 · 2026-08-20
- Hands-on with Instinct, Grok Bots and ChatGPT Work: personal agents compared — illscience · 2026-08-20
- Kids aged 9 and 11 build a game with ChatGPT voice mode while parents work — athyuttamre · 2026-08-20